$IPSI
Innovative Payment Solutions, Inc. Stock $ipsi

$ipsi Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022071662 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$850.00		$0.00
YoY Change
Cost Of Revenue	$5.050K		$0.00
YoY Change
Gross Profit	-$4.200K		$0.00
YoY Change
Gross Profit Margin	-494.12%
Selling, General & Admin	$1.155M	$2.721M	$2.748M
YoY Change	39.49%	-0.95%	715.63%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$102.9K	$20.50K	$4.640K
YoY Change	2112.9%	341.81%	11.54%
% of Gross Profit
Operating Expenses	$1.257M	$2.742M	$2.752M
YoY Change	51.07%	-0.38%	707.04%
Operating Profit	-$1.262M	-$2.742M	-$2.752M
YoY Change	51.58%	-0.38%	707.04%
Interest Expense	-$4.183M	$33.56K	$1.009M
YoY Change	2598.1%	-96.67%	-195.0%
% of Operating Profit
Other Income/Expense, Net	$1.322M	-$602.1K	$0.00
YoY Change			-100.0%
Pretax Income	-$4.123M	-$3.310M	-$1.743M
YoY Change	232.14%	89.92%	2.13%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$4.109M	-$3.303M	-$1.743M
YoY Change	234.47%	89.48%	2.13%
Net Earnings / Revenue	-483465.88%
Basic Earnings Per Share		-$0.01	$0.00
Diluted Earnings Per Share	-$0.01	-$0.01	-$4.779K
COMMON SHARES
Basic Shares Outstanding	376.9M shares	367.9M shares	356.5M shares
Diluted Shares Outstanding		376.0M shares	364.7M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$374.8K	$1.353M	$6.531M
YoY Change	-93.12%	-79.28%	5150.12%
Cash & Equivalents	$374.8K	$1.353M	$6.531M
Short-Term Investments
Other Short-Term Assets	$97.04K	$133.9K	$59.11K
YoY Change	14.12%	126.49%	581.78%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$471.8K	$1.487M	$6.590M
YoY Change	-91.48%	-77.44%	4852.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$40.36K	$52.43K	$33.44K
YoY Change	40.15%	56.8%	-67.83%
Goodwill
YoY Change
Intangibles	$1.693M	$1.198M
YoY Change	170.85%
Long-Term Investments	$500.0K	$500.0K	$500.0K
YoY Change	0.0%	0.0%
Other Assets	$47.59K	$47.59K	$4.800K
YoY Change	36.75%	891.46%	20.0%
Total Long-Term Assets	$2.281M	$1.798M	$788.2K
YoY Change	91.89%	128.11%	630.12%
TOTAL ASSETS
Total Short-Term Assets	$471.8K	$1.487M	$6.590M
Total Long-Term Assets	$2.281M	$1.798M	$788.2K
Total Assets	$2.753M	$3.285M	$7.379M
YoY Change	-59.06%	-55.48%	2961.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$761.7K	$574.8K	$453.3K
YoY Change	63.74%	26.82%	10.62%
Accrued Expenses			$0.00
YoY Change			-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$3.231M	$2.211M	$1.434M
YoY Change	64.73%	54.18%	130.97%
Long-Term Debt Due	$0.00		$60.29K
YoY Change			0.0%
Total Short-Term Liabilities	$6.543M	$3.496M	$2.768M
YoY Change	130.91%	26.28%	-15.4%
LONG-TERM LIABILITIES
Long-Term Debt	$164.0K	$162.6K	$156.9K
YoY Change	3.56%	3.58%	3.72%
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$164.0K	$162.6K	$156.9K
YoY Change	3.55%	3.58%	-7.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.543M	$3.496M	$2.768M
Total Long-Term Liabilities	$164.0K	$162.6K	$156.9K
Total Liabilities	$6.707M	$3.659M	$2.925M
YoY Change	124.17%	25.06%	-15.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$52.40M	-$48.29M
YoY Change	24.43%
Common Stock	$37.69K	$37.69K
YoY Change	2.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.956M	-$389.2K	$4.453M
YoY Change
Total Liabilities & Shareholders Equity	$2.753M	$3.285M	$7.379M
YoY Change	-59.06%	-55.48%	2961.24%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$4.109M	-$3.303M	-$1.743M
YoY Change	234.47%	89.48%	2.13%
Depreciation, Depletion And Amortization	$102.9K	$20.50K	$4.640K
YoY Change	2112.9%	341.81%	11.54%
Cash From Operating Activities	-$741.5K	-$867.8K	-$490.5K
YoY Change	2.36%	76.91%	-27.58%
INVESTING ACTIVITIES
Capital Expenditures	$236.7K	-$298.3K	-$250.0K
YoY Change	-163.12%	19.34%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$12.79K	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$236.7K	-$311.1K	-$250.0K
YoY Change	-41.56%	24.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	0.000
YoY Change	-100.0%		-100.0%
NET CHANGE
Cash From Operating Activities	-741.5K	-867.8K	-490.5K
Cash From Investing Activities	-236.7K	-311.1K	-250.0K
Cash From Financing Activities	0.000	0.000	0.000
Net Change In Cash	-978.2K	-1.179M	-740.5K
YoY Change	-9.54%	59.2%	-697.87%
FREE CASH FLOW
Cash From Operating Activities	-$741.5K	-$867.8K	-$490.5K
Capital Expenditures	$236.7K	-$298.3K	-$250.0K
Free Cash Flow	-$978.2K	-$569.4K	-$240.5K
YoY Change	179.97%	136.75%	-64.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Revenues Revenues		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2021Q3	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Gross Profit GrossProfit		usd
CY2022Q3	qpag	Gain Loss On Debt Conversion GainLossOnDebtConversion		usd
CY2021Q3	qpag	Gain Loss On Debt Conversion GainLossOnDebtConversion		usd
CY2021Q3	qpag	Penalty On Convertible Notes PenaltyOnConvertibleNotes		usd
	qpag	Penalty On Convertible Notes PenaltyOnConvertibleNotes		usd
CY2022Q3	qpag	Amortization Of Debt Discount AmortizationOfDebtDiscount		usd
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	323034956	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	364722331	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	370615966	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	375956027	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55648
	dei	Entity Registrant Name EntityRegistrantName	INNOVATIVE PAYMENT SOLUTIONS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-1230229
	dei	Entity Address Address Line1 EntityAddressAddressLine1	56B 5th Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Lot 1 #AT
	dei	Entity Address City Or Town EntityAddressCityOrTown	Carmel By The Sea
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93921
	dei	City Area Code CityAreaCode	(866)
	dei	Local Phone Number LocalPhoneNumber	477-4729
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	376901679	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1352983	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5449751	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	133880	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	85034	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	1486863	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	5534785	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	52434	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28799	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1198011	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	625000	usd
CY2022Q3	us-gaap	Security Deposit SecurityDeposit	47592	usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	34800	usd
CY2022Q3	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	500001	usd
CY2021Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	500001	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	1798038	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1188600	usd
CY2022Q3	us-gaap	Assets Assets	3284901	usd
CY2021Q4	us-gaap	Assets Assets	6723385	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	574825	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	465205	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	263200	usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2210802	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1961354	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	710389	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	407161	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3496016	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2833720	usd
CY2022Q3	qpag	Federal Relief Loans Non Current FederalReliefLoansNonCurrent	162560	usd
CY2021Q4	qpag	Federal Relief Loans Non Current FederalReliefLoansNonCurrent	158353	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	162560	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	158353	usd
CY2022Q3	us-gaap	Liabilities Liabilities	3658576	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2992073	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	376901679	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	376901679	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	367901679	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	367901679	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	37690	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	36790	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	47863546	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45771012	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48290394	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-42111701	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-389158	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3696101	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	15483	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	35211	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-373675	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3731312	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3284901	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6723385	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2721451	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2747693	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4386375	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9457134	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20500	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4642	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29493	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13293	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2741951	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	2752335	usd
	us-gaap	Operating Expenses OperatingExpenses	4415868	usd
	us-gaap	Operating Expenses OperatingExpenses	9470427	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2741951	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2752335	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4415868	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9470427	usd
	qpag	Gain Loss On Debt Conversion GainLossOnDebtConversion	-5184447	usd
CY2022Q3	qpag	Penalty On Convertible Notes PenaltyOnConvertibleNotes	-602100	usd
	qpag	Penalty On Convertible Notes PenaltyOnConvertibleNotes	-1321658	usd
CY2022Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	51340	usd
CY2021Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	53903	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	142302	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	174587	usd
CY2021Q3	qpag	Amortization Of Debt Discount AmortizationOfDebtDiscount	-515200	usd
	qpag	Amortization Of Debt Discount AmortizationOfDebtDiscount	-263200	usd
	qpag	Amortization Of Debt Discount AmortizationOfDebtDiscount	-3138452	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	94462	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	62766	usd
CY2022Q3	qpag	Derivative Liability Movement DerivativeLiabilityMovement	-84895	usd
CY2021Q3	qpag	Derivative Liability Movement DerivativeLiabilityMovement	-1578361	usd
	qpag	Derivative Liability Movement DerivativeLiabilityMovement	65046	usd
	qpag	Derivative Liability Movement DerivativeLiabilityMovement	-4714451	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3310496	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1743077	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6208074	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13253462	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-3310496	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-1743077	usd
	us-gaap	Profit Loss ProfitLoss	-6208074	usd
	us-gaap	Profit Loss ProfitLoss	-13253462	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-7652	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-29381	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3302844	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1743077	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6178693	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13253462	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	375956027	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	364722331	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	370615966	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	323034956	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3731312	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	94466	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	62766	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1810246	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2078298	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	9653	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1087332	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1157847	usd
CY2022Q3	qpag	Stock Issued During Period Value Fair Value Of Warrants Issued StockIssuedDuringPeriodValueFairValueOfWarrantsIssued	322918	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	333000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	110000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1013056	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-3310496	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-373675	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4430813	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2203714	usd
CY2021Q1	qpag	Stock Issue During Period Value Share Subscriptions StockIssueDuringPeriodValueShareSubscriptions	4550000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-501100	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	7443668	usd
CY2021Q1	qpag	Stock Issued During Period Value Fair Value Of Warrants Issued StockIssuedDuringPeriodValueFairValueOfWarrantsIssued	4327899	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	213749	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-11394106	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2413011	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	805635	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	776000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	72141	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-116279	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3950508	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	443050	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1802682	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-1743077	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4453163	usd
	us-gaap	Profit Loss ProfitLoss	-6208074	usd
	us-gaap	Profit Loss ProfitLoss	-13253462	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	65046	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-4714451	usd
	us-gaap	Depreciation Depreciation	29493	usd
	us-gaap	Depreciation Depreciation	13293	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	263200	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3138452	usd
	qpag	Loss On Conversion Of Debt To Equity LossOnConversionOfDebtToEquity	5184447	usd
	qpag	Penalty On Convertible Debt PenaltyOnConvertibleDebt	1321658	usd
	qpag	Deposit Forfeited DepositForfeited	4000	usd
	qpag	Proceeds From Shares Issued For Services ProceedsFromSharesIssuedForServices	333000	usd
	qpag	Proceeds From Shares Issued For Services ProceedsFromSharesIssuedForServices	1219050	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1437516	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6416471	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	322918	usd
	qpag	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	17857	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	48846	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	53834	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	109621	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	17545	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-17857	usd
	qpag	Increase Decrease In Interest Accruals IncreaseDecreaseInInterestAccruals	54042	usd
	qpag	Increase Decrease In Interest Accruals IncreaseDecreaseInInterestAccruals	144773	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2320426	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1883716	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	585640	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	250000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	500000	usd
	qpag	Investment In Deposits InvestmentInDeposits	12792	usd
	qpag	Investment In Deposits InvestmentInDeposits	4800	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40500	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9234	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-638932	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-764034	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	9653	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4550000	usd
	qpag	Share Issue Expenses ShareIssueExpenses	501100	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3009349	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	22049	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1147063	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	521000	usd
	qpag	Proceeds From Short Term Notes And Convertible Notes ProceedsFromShortTermNotesAndConvertibleNotes	2569000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1137410	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9084200	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4096768	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6436450	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5449751	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94703	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1352983	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6531153	usd
	us-gaap	Interest Paid Net InterestPaidNet	88260	usd
	us-gaap	Interest Paid Net InterestPaidNet	29813	usd
	qpag	Derecognition Of Right Of Use Lease On Early Termination DerecognitionOfRightOfUseLeaseOnEarlyTermination	34070	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	2259221	usd
CY2019Q4	qpag	Reverse Stock Split Description ReverseStockSplitDescription	On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.
CY2019Q4	qpag	Stock Purchase Agreement StockPurchaseAgreement	On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi” or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%).
CY2021Q3	qpag	Percentage Of Remaining Shares Owned PercentageOfRemainingSharesOwned	0.49	pure
	qpag	Beyond Fintech Inc Owned Percentage BeyondFintechIncOwnedPercentage	0.51	pure
	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>c)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Use of Estimates</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>f)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Risks and Uncertainties</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q3	qpag	Federally Insured Limit FederallyInsuredLimit	1094504	usd
CY2021Q4	qpag	Federally Insured Limit FederallyInsuredLimit	5117551	usd
CY2022Q3	qpag	Equity Methods Investment Ownership Percentage EquityMethodsInvestmentOwnershipPercentage	0.20	pure
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1000	usd
	qpag	Schedule Of Estimated Useful Lives Of Assets ScheduleOfEstimatedUsefulLivesOfAssets	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 50%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 1%"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Kiosks (not used in the Company’s current business)</span></td> <td> </td> <td><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td><span style="font-size: 10pt">Lesser of estimated useful life or life of lease</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td><span style="font-size: 10pt">10 years</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>s)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Reclassification of prior year presentation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span></p>
	qpag	Net Income Loss Attributable Noncontrolling Interest NetIncomeLossAttributableNoncontrollingInterest	6208074	usd
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1352983	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000	usd
CY2021Q3	qpag	Fintech Percentage FintechPercentage	0.51	pure
CY2021Q3	qpag	Owned Frictionless Financial Technologies OwnedFrictionlessFinancialTechnologies	0.49	pure
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	375000	usd
CY2022Q3	us-gaap	General Partners Offering Costs GeneralPartnersOfferingCosts	544320	usd
	qpag	Additional Amount Of Software AdditionalAmountOfSoftware	41320	usd
CY2022Q3	qpag	Purchased Technology PurchasedTechnology	1210640	usd
CY2021Q4	qpag	Purchased Technology PurchasedTechnology	625000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12629	usd
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1198011	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	625000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12629	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12629	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2019	qpag	Investment Description InvestmentDescription	Effective December 31, 2019, the Company sold 100% of the outstanding common stock of its subsidiary, Qpagos Corporation, together with its 99.9% ownership interest of Qpagos Corporation’s two Mexican entities: Qpagos S.A.P.I. de C.V. and Redpag Electrónicos S.A.P.I. de C.V, to Vivi.
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2047500	shares
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	1019960	usd
CY2021	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	1019960	usd
CY2022Q3	us-gaap	Investments Investments	500001	usd
CY2021Q4	us-gaap	Investments Investments	500001	usd
	us-gaap	Lease Cost LeaseCost	4800	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	43200	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	17857	usd
	qpag	Schedule Of Other Lease Information ScheduleOfOtherLeaseInformation	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Nine <br/> months ended<br/> September 30,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Nine <br/> months ended<br/> September 30,<br/> 2021</b></span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt"><b>Cash paid for amounts included in the measurement of lease liabilities</b></span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%"><span style="font-size: 10pt">Operating cash flows from operating leases</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-size: 10pt">(45,200</span></td> <td style="width: 1%"><span style="font-size: 10pt">)</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-size: 10pt">(60,403</span></td> <td style="width: 1%"><span style="font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">Remaining lease term – operating lease</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-169; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">6 months</span></td> <td> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p>
	qpag	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	-45200	usd
	qpag	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	-60403	usd
	qpag	Remaining Lease Term Operating Lease RemainingLeaseTermOperatingLease	P6M
CY2020Q3	qpag	Disaster Loan Amount DisasterLoanAmount	150000	usd
CY2020Q3	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.0375	pure
CY2020Q3	qpag	Repayable Installments RepayableInstallments	731	usd
	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	12560	usd
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	49912	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2021Q3	us-gaap	Interest Expense Other InterestExpenseOther	52236	usd
CY2022Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2021Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	515200	usd
	us-gaap	Interest Expense Other InterestExpenseOther	138085	usd
	us-gaap	Interest Expense Other InterestExpenseOther	169695	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	263200	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	3138452	usd
CY2021Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2486957	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.24
CY2022Q3	qpag	Shares Of Common Stock SharesOfCommonStock	3000000	shares
CY2022Q3	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.15
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	238182	usd
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	710389	usd
CY2022Q3	qpag	Derivative Liability Credited DerivativeLiabilityCredited	84895	usd
	qpag	Derivative Liability Credited DerivativeLiabilityCredited	65046	usd
CY2021	qpag	Fair Value Adjustment To Derivative Liability FairValueAdjustmentToDerivativeLiability	-5128255	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	710389	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	407161	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	376901679	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	407161	usd
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2966416	usd
	qpag	Derivative Financial Liability Arising From Convertible Note DerivativeFinancialLiabilityArisingFromConvertibleNote	238182	usd
CY2021	qpag	Derivative Financial Liability Arising From Convertible Note DerivativeFinancialLiabilityArisingFromConvertibleNote	2569000	usd
	qpag	Fair Value Adjustment To Derivative Liability FairValueAdjustmentToDerivativeLiability	65046	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2022Q3	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	376901679	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	367901679	shares
CY2021Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	367901679	shares
CY2022Q3	us-gaap	Shares Issued SharesIssued	2000000	shares
CY2022Q3	qpag	Value Of Grant Date ValueOfGrantDate	84000	usd
CY2022Q3	qpag	Agreement Fee AgreementFee	3000	usd
CY2022Q3	qpag	Value Of Grant Date ValueOfGrantDate	110000	usd
CY2022Q3	qpag	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Grant Value SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicGrantValue	165000	usd
	qpag	Restricted Stock Granted Shares RestrictedStockGrantedShares	23495000	shares
	qpag	Restricted Stock Granted Weighted Average Fair Value Per Share RestrictedStockGrantedWeightedAverageFairValuePerShare	0.05
	qpag	Restricted Stock Vested Numbe Shares RestrictedStockVestedNumbeShares	18371250	shares
	qpag	Restricted Stock Vested Weighted Average Fair Value Per Share RestrictedStockVestedWeightedAverageFairValuePerShare	0.05
	qpag	Proceeds From Short Term Notes And Convertible Notes ProceedsFromShortTermNotesAndConvertibleNotes		usd
CY2022Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	172766	usd
CY2021Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	44165	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	298298	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	188448	usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share.
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3000000	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.15
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	58304105	shares
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y4M2D
CY2022Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.11
CY2022Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	51741605	shares
CY2022Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.11
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P3Y5M1D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q3	qpag	Description Of Ranted Options Exercisable DescriptionOfRantedOptionsExercisable	On September 13, 2022, the Company granted ten-year options exercisable for 200,000 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 800,000 shares of Common Stock at an exercise price of $0.04 per share.
CY2022Q3	qpag	Amount Of Immediate Expense AmountOfImmediateExpense	31970	usd
	qpag	Amount Of Immediate Expense AmountOfImmediateExpense	31970	usd
	qpag	Share Based Compensation Arrangements By Share Based Payment Award Option Outstanding ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionOutstanding	46316666	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y2M8D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.15
CY2022Q3	qpag	Options Exercisable Number Exercisablein OptionsExercisableNumberExercisablein	36733333	shares
CY2022Q3	qpag	Options Exercisable Weighted Average Exercise Price OptionsExercisableWeightedAverageExercisePrice	0.15
	qpag	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm	P9Y3M7D
CY2022Q3	qpag	Intrinsic Value Outstanding Options IntrinsicValueOutstandingOptions	0	usd
CY2021Q4	qpag	Intrinsic Value Outstanding Options IntrinsicValueOutstandingOptions	0	usd
CY2022Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	950290	usd
CY2021Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1196566	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1139220	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1288174	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	119359453	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	119359453	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	81447436	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	81447436	shares
CY2021Q1	qpag	Share Of Common Stock ShareOfCommonStock	208333	shares
CY2021Q1	qpag	Exercise Price ExercisePrice	0.24
	qpag	Salary Rate SalaryRate	1	pure
	qpag	Annual Meeting Of Stockholders Description AnnualMeetingOfStockholdersDescription	At the Annual Meeting, the Company’s stockholders (i) elected each of William D. Corbett, Richard Rosenblum, Madisson Corbett, Clifford Henry and David Rios as directors’ of the Company until the next annual meeting or until their successors shall be elected and qualified, (ii) ratified the appointment of RBSM LLP as the Company’s independent registered public accounting firm for fiscal year ended December 31, 2022, (iii) approved an amendment to the Company’s Articles of Incorporation to effect a reverse stock split of the issued and outstanding shares of common stock at a ratio (to be determined in the discretion of the Company’s Board during a two year period ending on November 2, 2024) within a range of one (1) share of Common Stock for every two (2) to thirty (30) shares of Common Stock, and (iv) approved a potential adjournment of the annual meeting,
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
	qpag	Gain Loss On Debt Conversion GainLossOnDebtConversion		usd
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	qpag	Loss On Conversion Of Debt To Equity LossOnConversionOfDebtToEquity		usd
	qpag	Penalty On Convertible Debt PenaltyOnConvertibleDebt		usd
	qpag	Deposit Forfeited DepositForfeited		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	qpag	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset		usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	qpag	Share Issue Expenses ShareIssueExpenses		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	qpag	Derecognition Of Right Of Use Lease On Early Termination DerecognitionOfRightOfUseLeaseOnEarlyTermination		usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
	qpag	Remaining Lease Term Operating Lease RemainingLeaseTermOperatingLease
CY2022Q3	qpag	Undiscounted Minimum Future Lease Payments UndiscountedMinimumFutureLeasePayments		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001591913
	dei	Security Exchange Name SecurityExchangeName	NONE
	dei	Security12b Title Security12bTitle	N/A
	dei	Trading Symbol TradingSymbol	N/A

Files In Submission

Name	View Source	Status
0001213900-22-071662-index-headers.html	Edgar Link	pending
0001213900-22-071662-index.html	Edgar Link	pending
0001213900-22-071662.txt	Edgar Link	pending
0001213900-22-071662-xbrl.zip	Edgar Link	pending
f10q0922ex31-1_innovative.htm	Edgar Link	pending
f10q0922ex31-2_innovative.htm	Edgar Link	pending
f10q0922ex32-1_innovative.htm	Edgar Link	pending
f10q0922ex32-2_innovative.htm	Edgar Link	pending
f10q0922_innovative.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qpag-20220930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
qpag-20220930_def.xml	Edgar Link	unprocessable
qpag-20220930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
qpag-20220930_cal.xml	Edgar Link	unprocessable
f10q0922_innovative_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
qpag-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IPSI
Innovative Payment Solutions, Inc. Stock $ipsi

2022 Q4 Form 10-Q Financial Statement

#000121390022071662 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IPSI Innovative Payment Solutions, Inc. Stock $ipsi

2022 Q4 Form 10-Q Financial Statement

#000121390022071662 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IPSI
Innovative Payment Solutions, Inc. Stock $ipsi